Lichter Jay
10% owner at JANX; Director at Otonomy, Inc.; Director, 10% owner at ARATANA THERAPEUTICS, INC.
- Sold, on record
- $105M
- Dollars the filings state
- Form 4 sales
- 7
- Latest Sep 13, 2024
- Form 144 notices
- 0
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- JANXJanux Therapeutics, Inc.10% owner
- Otonomy, Inc.Director
- ARATANA THERAPEUTICS, INC.Director, 10% owner
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Otonomy, Inc.2.3M shares
- JANX1.5M shares
- ARATANA THERAPEUTICS, INC.825,000 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale ARATANA THERAPEUTICS, INC.Plan not statedFeb 3 2014
Sold 825,000 shares at $19.00 ($15.7M)
Lichter Jay, Director, 10% owner
Sold 19.8% of holdings ($79.2M position)3.3M shares leftFirst sale on recordFiling
- 2 Form 4 sale Otonomy, Inc.Plan not statedAug 18 +196 days
Sold 50,001 shares at $16.00 ($800k)
Lichter Jay, Director, 10% owner
Sold 3.3% of holdings ($24M position)1.5M shares leftFirst sale on recordFiling
- 3 Form 4 sale Otonomy, Inc.UnusualFeb 25 +2383 days
Sold 1.1M shares at $2.95 ($3.2M)
Lichter Jay, Director
Sold 71.5% of holdings ($4.5M position)431,015 shares leftFirst sale on recordFiling
- 4 Form 4 sale Otonomy, Inc.UnusualMar 2 +5 days
Sold 893,828 shares at $2.87 ($2.6M)
Lichter Jay, Director
Sold 88.7% of holdings ($2.9M position)113,935 shares leftFiling
- 5 Form 4 sale Otonomy, Inc.UnusualMar 3 +1 day
Sold 321,180 shares at $2.70 ($867k)
Lichter Jay, Director
Sold 100% of holdings ($867k position)0 shares leftFiling
- 6 Form 4 sale JANXUnusualJun 3 +1188 days
Sold 1.5M shares at $54.75 ($82.1M)
Lichter Jay, Director, 10% owner
No 10b5-1 planSold 31% of holdings ($265M position)3.3M shares leftFirst sale on recordFiling
- 7 Form 4 sale JANXUnusualSep 13 +102 days
Sold 3,815 shares at $46.68 ($178k)
Lichter Jay, 10% owner
No 10b5-1 planSold 35.3% of holdings ($505k position)7,000 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (7)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2024 | JANX | 10% owner | Form 4 sale | 3,815 | $178k | 35.3% | Unusual | SEC |
| Jun 3, 2024 | JANX | Director, 10% owner | Form 4 sale | 1.5M | $82.1M | 31.0% | Unusual | SEC |
| Mar 3, 2021 | Otonomy, Inc. | Director | Form 4 sale | 321,180 | $867k | 100.0% | Unusual | SEC |
| Mar 2, 2021 | Otonomy, Inc. | Director | Form 4 sale | 893,828 | $2.6M | 88.7% | Unusual | SEC |
| Feb 25, 2021 | Otonomy, Inc. | Director | Form 4 sale | 1.1M | $3.2M | 71.5% | Unusual | SEC |
| Aug 18, 2014 | Otonomy, Inc. | Director, 10% owner | Form 4 sale | 50,001 | $800k | 3.3% | Plan not stated | SEC |
| Feb 3, 2014 | ARATANA THERAPEUTICS, INC. | Director, 10% owner | Form 4 sale | 825,000 | $15.7M | 19.8% | Plan not stated | SEC |